Dopamine Receptor D4 Genotype (DRD4), Saliva
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Influencing the target dose of methylphenidate treatment for patients with attention deficit/hyperactivity disorder
Determining possible cause for poor response to methylphenidate in treated patients with attention deficit/hyperactivity disorder
Genotyping patients who prefer not to have venipuncture done
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Polymerase Chain Reaction (PCR) Followed by Sizing Analysis
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
DRD4 Genotype, Saliva